Previous Article | Next Article 
Journal of Virology, June 1999, p. 4705-4712, Vol. 73, No. 6
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Phenotypic Consequences of Rearranging the P, M,
and G Genes of Vesicular Stomatitis Virus
L. Andrew
Ball,1,*
Craig R.
Pringle,2
Brian
Flanagan,1
Victoria P.
Perepelitsa,1 and
Gail
W.
Wertz1
Department of Microbiology, University of
Alabama at Birmingham, Birmingham, Alabama
35294,1 and Department of Biological
Sciences, University of Warwick, Coventry CV4 7AL,
England2
Received 8 February 1999/Accepted 9 March 1999
 |
ABSTRACT |
The nonsegmented negative-strand RNA viruses (order
Mononegavirales) include many important human pathogens.
The order of their genes, which is highly conserved, is the major
determinant of the relative levels of gene expression, since genes that
are close to the single promoter site at the 3' end of the viral genome are transcribed at higher levels than those that occupy more distal positions. We manipulated an infectious cDNA clone of the prototypic vesicular stomatitis virus (VSV) to rearrange three of the five viral
genes, using an approach which left the viral nucleotide sequence
otherwise unaltered. The central three genes in the gene order, which
encode the phosphoprotein P, the matrix protein M, and the glycoprotein
G, were rearranged into all six possible orders. Viable viruses were
recovered from each of the rearranged cDNAs. The recovered viruses were
examined for their levels of gene expression, growth potential in cell
culture, and virulence in mice. Gene rearrangement changed the
expression levels of the encoded proteins in concordance with their
distance from the 3' promoter. Some of the viruses with rearranged
genomes replicated as well or slightly better than wild-type
virus in cultured cells, while others showed decreased replication. All
of the viruses were lethal for mice, although the time to symptoms and
death following inoculation varied. These data show that despite the highly conserved gene order of the Mononegavirales, gene
rearrangement is not lethal or necessarily even detrimental to the
virus. These findings suggest that the conservation of the gene order
observed among the Mononegavirales may result from
immobilization of the ancestral gene order due to the lack of a
mechanism for homologous recombination in this group of viruses. As a
consequence, gene rearrangement should be irreversible and provide an
approach for constructing viruses with novel phenotypes.
 |
INTRODUCTION |
Vesicular stomatitis virus (VSV) is
the prototype virus of the order Mononegavirales, the
nonsegmented negative-strand RNA viruses that include the
causative agents of many serious infectious diseases
(32). The negative-sense RNA genomes of these viruses contain five to 10 genes whose expression is controlled at the level of transcription by the viral RNA-dependent RNA polymerase. The
polymerase initiates transcription at a single promoter site near the
3' end of the viral RNA, and transcription is obligatorily sequential
(1, 3), but attenuation at each intergenic junction results
in a progressive decrease in the transcription of genes that are
further from the promoter (18, 41). It has been suggested that this simple method of regulation probably accounts in part for
the observation that the gene order within the
Mononegavirales is highly conserved (32);
proteins that are required in large amounts, such as the nucleocapsid
protein (N), are encoded in promoter-proximal genes, whereas those
that are needed only in catalytic amounts, such as the large subunit
(L) of the RNA polymerase, are encoded more distally. The gene order of
VSV, as follows, is typical: 3' - N - P - M - G - L - 5'.
The replication of VSV can be modulated by changing the relative levels
of the individual viral proteins. For example, cells that express the
VSV L protein from a vector can complement an L gene mutant virus only
if their levels of L expression are low (23), a result that
is consistent with the fact that the L gene is furthest from the
promoter in VSV and in every other member of the
Mononegavirales (32). Furthermore, when the
replication of VSV defective interfering (DI) RNAs or genome analogs is
supported by the viral N, P, and L proteins expressed in
trans from individual vectors, precise molar ratios of
the three proteins are needed to achieve optimal RNA replication
(29). Since the L and P proteins are subunits of the viral
RNA polymerase (12), and N and P form complexes that are
involved in encapsidation of the RNA template (16, 19), the
sensitivity of RNA replication to the N:P:L ratio probably
reflects the formation of several different macromolecular complexes during the viral life cycle.
In recent work, we translocated the gene for the nucleocapsid
protein of VSV, which is required in stoichiometric amounts to
support RNA replication, from its promoter proximal position to second,
third, or fourth in the gene order (45). Translocation of
the N gene to successive downstream positions resulted in the reduction
of N protein synthesis in a stepwise manner, demonstrating directly
that the position of a gene determined its level of expression. The
sequential translocation of the N gene and the attendant reduction of N
protein synthesis resulted also in a stepwise reduction in the ability
of these viruses to replicate in cell culture and in their lethality
for animals (45). These studies showed that translocation of
a gene whose product was required in stoichiometric amounts for
replication could systematically down-regulate gene expression and
concomitantly reduce viral replication and lethality for mice. This
provides a rational approach to the generation of attenuated viruses as
candidates for vaccines or vectors.
Less is known about the quantitative requirements for the M and G
proteins. They are required for the assembly and budding of infectious
particles (20, 22, 28, 48), but since M protein inhibits
viral and host cell transcription (2, 9, 26) and is
cytopathic (7), it is likely that the relative levels of M
can also affect overall levels of viral transcription and thereby
levels of progeny virus production. Indeed, since the five viral
proteins are made in similar ratios throughout infection, with little
if any differential temporal modulation, their relative intracellular
concentrations probably affect the timing of several stages of the
replication cycle, including the onset of RNA encapsidation, genome
replication, secondary transcription, nucleocapsid condensation, and
virus budding. Thus, in view of the delicate balance that often exists
between virus replication on the one hand and the cellular and
organismal defense mechanisms on the other, perturbing the expression
levels, even of wild-type proteins, should have significant
consequences for the phenotype of the virus.
In light of our previous work showing that translocation of the N gene
to promoter distal positions reduced gene expression in a systematic
manner (45), we rearranged the order of the genes encoding
the VSV P, M, and G proteins relative to the single polymerase entry
site. Using a full-length cDNA clone of the VSV genome from which we
had previously recovered infectious virus (47), we
constructed variant cDNAs in which the P, M, and G genes were arranged
in all possible orders. This was done with the expectation that such
changes would alter levels of gene expression according to their
respective distance to the promoter and, thus, the expression of some
genes would be increased while that of others would be decreased in
comparison to the wild-type levels. The present report documents the
recovery of viable viruses from all of the rearranged cDNAs along with
the characterization of their levels of gene expression, ability to
replicate in cell culture and lethality for animals. The results show
that the virus is remarkably tolerant of the rearrangement of the
central three genes. Further, gene rearrangement provides a method for
manipulating the phenotypes of this category of viruses which may
illuminate aspects of the viral replication cycle and interactions of
the virus with its host. Moreover, since the Mononegavirales
have not been observed to undergo homologous recombination (30,
31), gene rearrangement should be irreversible.
 |
MATERIALS AND METHODS |
Viruses and cells.
The San Juan isolate of the Indiana
serotype of VSV provided the original RNA template for most of the cDNA
clones used in this work (47); however, the G protein gene
was originally derived from the Orsay isolate of VSV Indiana. Baby
hamster kidney (BHK-21) cells were used for virus recovery from cDNAs
(47) and for radioisotopic labeling of RNAs and proteins.
Single-step growth experiments were performed in African green monkey
kidney (BSC-1 and BSC-40) cells, and these were also used for plaque assays.
Plasmid construction and the recovery of infectious viruses.
Construction of a full-length cDNA clone of the genome of VSV and the
recovery of infectious virus from it have been described before
(47). This infectious clone was used as a template for the
construction of cDNA clones of the individual viral genes or segments
of genes, which were then reassembled in several different orders as
described in Results. Standard methods of DNA manipulation (37) were used for plasmid construction throughout. To
recover infectious viruses from full-length cDNA clones, BHK-21 cells were infected with the vaccinia virus (VV) recombinant that expresses T7 RNA polymerase (vTF7-3 [15]) and transfected with
the rearranged plasmids, together with three support plasmids that
expressed the N, P, and L proteins that are required for RNA
encapsidation and replication (29). Infectious viruses were
recovered from the supernatant medium, amplified by passage on BHK-21
cells at low multiplicity to avoid the occurrence of DI particles,
filtered through 0.2-µM-pore-size filters, and banded in sucrose
velocity gradients to remove contaminating VV. The gene orders of the
recovered viruses were verified by amplifying the rearranged portions
of the viral genomes by reverse transcription-PCR and analyzing the patterns of DNA fragments that resulted from digestion of the PCR
products with restriction enzymes.
Single-cycle virus replication.
Monolayer cultures of 4 × 105 BSC-1 cells were infected with individual viruses at
an input multiplicity of 5 PFU per cell. Following a 1-h adsorption
period, the inoculum was removed, the cells were washed twice, fresh
medium was added, and the cultures were incubated at 37°C. Samples of
the medium were harvested at the indicated intervals over a 25-h
period, and viral replication was quantitated by plaque assay on
confluent monolayers of BSC-1 cells.
Analysis of viral RNA and protein synthesis.
Confluent
monolayers of BHK-21 cells were infected with individual viruses at an
input multiplicity of 5 PFU per cell, using a 1-h adsorption period.
Viral RNA synthesis was analyzed at 1.5 h postinfection at 37°C
by treating the cultures with actinomycin D (5 µg per ml) for 30 min
prior to the addition of [3H]uridine (30 µCi per ml)
for a 2- or 4-h labeling period. Cells were harvested, cytoplasmic
extracts were prepared, and purified RNAs were analyzed on 1.75%
agarose-urea gels as described previously (43). Protein
synthesis was analyzed at 4 h postinfection at 37°C by adding
[35S]methionine (40 µCi per ml) for a 30-min labeling
period following a 30-min incubation in methionine-free medium.
Cytoplasmic extracts were prepared, and proteins were analyzed by
electrophoresis on 10% polyacrylamide-sodium dodecyl sulfate (SDS)
gels as described previously (29). Individual RNAs and
proteins were quantitated by phosphorimaging or by densitometric
analysis of autoradiographs of gels. Molar ratios were calculated after
adjustment for the uridine or methionine contents of individual RNA or
protein species, respectively.
Virulence in mice.
The virulence of individual viruses was
measured in 3- to 4-week-old male Swiss-Webster mice obtained from
Taconic Farms (Germantown, N.Y.) and held under BL2 containment
conditions, which are appropriate for laboratory strains of VSV Indiana
(34). Groups of five or six mice were lightly anesthetized
with ketamine and xylazine, and the animals were inoculated
intranasally with 10- or 15-µl aliquots of serial tenfold dilutions
of the individual viruses or with diluent Dulbecco modified Eagle
medium. Animals were observed every 12 or 24 h, and the 50%
lethal dose (LD50) for each virus was calculated by the
method of Reed and Muench (33). Viruses were recovered from
the brains of mice shortly after death and passed once in cell culture,
and their gene orders were verified as described above.
 |
RESULTS |
A general approach to rearranging the genes of the
Mononegavirales.
To rearrange the genes of VSV without
introducing other changes into the viral genome, we used PCR to
construct individual cDNA clones of the P, M, and G genes that
were flanked by sites for BspM1, a restriction enzyme that
cuts outside its recognition sequence. PCR primers were designed to
position these restriction sites so that the four-base cohesive ends
left after BspM1 digestion corresponded to the
3'...UGUC...5' sequence of the conserved
3'...UUGUC...5' that occurs at the start of each VSV gene.
Thus, a typical PCR product had the following sequence:
3'...TGGACGTGATTGTC........TTTTTTTGATTGTCTCTACGTCCA...5', where the VSV cDNA sequence, written in the negative sense, is in
bold, the BspM1 recognition sites are in italics, and the
four-base cohesive ends left by BspM1 digestion are
underlined. In this way, the three genes together with their following
intergenic junctions were recovered on individual DNA fragments that
had compatible cohesive termini. The only deliberate departure from the
wild-type sequence was that the untranscribed intergenic dinucleotide following the P gene, which is 3'CA5' in wild-type virus, was made
3'GA5', to conform with all the other intergenic junctions. This
mutation appeared to be silent (4). To circumvent spurious mutations arising during PCR, the termini of the individually cloned
genes were sequenced, and the interiors of the P and G genes were
replaced with corresponding DNA fragments from the infectious clone.
Two other starting plasmids were required to reconstruct the rearranged
full-length clones. One contained the first 420 nucleotides of the L
gene and had a unique BspM1 site positioned to cut within the 3'...UUGUC...5' sequence at the start of L as follows:
3'...TGGACGTGATTGTCGTTAGTAC...(L gene)...5'. The other contained the last 360 nucleotides of the N gene and had a unique BspM1 site positioned to cut
within the same sequence right after N as follows: 3'...(N
gene)...TTTTTTTGATTGTCTCTACGTCCA...5'. The
different typefaces have the same meanings as above. The DNA fragments
encompassing the P, M, and G genes were ligated unidirectionally into
the unique BspM1 site of the L gene plasmid to rebuild the rearranged viral genomes one gene at a time from the L gene end. Insertion of each gene recreated a wild-type intergenic junction and
left a unique BspM1 site to receive the next gene. At each step of the reconstructions, the nucleotide sequences of the newly created intergenic junctions were confirmed. Reconstruction of the
full-length circular plasmids was completed by adding a 10-kb DNA
fragment from the wild-type infectious clone (47) that
encompassed the remaining 6 kb of the L gene, the trailer end of the
viral genome, the hepatitis delta virus ribozyme and T7 terminator
(which are needed for the intracellular synthesis of
replication-competent transcripts [27]), the pGEM3
vector sequence, the T7 promoter, and 1,035 nucleotides from the 3' end
of the viral genome.
To validate this cloning strategy and to verify that the individual
genes encoded functional proteins, we used the same procedure
to
recreate the wild-type gene order in parallel with the rearranged
cDNAs
and then tested all six plasmids for their ability to yield
infectious
viruses, as described before (
47). Viable viruses
were
recovered that had the P, M, and G genes in all six possible
orders
(Fig.
1). Virus recovered from the
wild-type plasmid was
designated VSV N1 (PMG) and was used throughout
this work as the
wild-type virus. Its replication in cell culture was
indistinguishable
from that of nonrecombinant VSV Indiana (data not
shown).

View larger version (32K):
[in this window]
[in a new window]
|
FIG. 1.
Schematic representations (not to scale) of the gene
orders of wild-type VSV and the rearranged variant viruses. The
wild-type (wt) virus used throughout this work was recovered from a
cDNA clone that was reconstructed in parallel with the rearranged
viruses by using the same individual gene clones; it was previously
designated VSV N1 (PMG) to emphasize this distinction (45).
The variant viruses were named according to the order of their central
three genes. le, leader; tr, trailer.
|
|
The gene orders of the recovered viruses were determined after three
passages in cell culture by amplifying a 4.1-kb fragment
encompassing
the rearranged portions of the viral genomes by reverse
transcription
and PCR, followed by restriction enzyme analysis
of the PCR products.
PCR was carried out with primers located
in the N and L genes. After
cleavage with restriction endonuclease
AccI,
BglII, or
PstI, which cleave uniquely in the P,
M, or G
gene, respectively, the observed sizes of the digestion
products
were found to be exactly as predicted (Fig.
2a and
b). The data
in Fig.
2 show that the gene
orders of the recovered viruses corresponded
to the cDNA clones from
which they were recovered. There was no
evidence for the reappearance
of the wild-type gene order among
the variants.

View larger version (70K):
[in this window]
[in a new window]
|
FIG. 2.
Determination of gene order in recovered viral genomes.
Genomic RNA was isolated from recovered viruses and analyzed by reverse
transcription and PCR, followed by restriction enzyme analysis of the
PCR products. (a) Schematic diagram of the VSV genome showing positions
of PCR primers that annealed to the N or L genes, respectively (shown
by the arrows) and restriction enzyme cleavage sites and predicted
fragment sizes. (b) Products after digestion with indicated enzymes of
the cDNAs of viral RNA from viruses GMP, MGP, PGM, PMG, GPM, and MPG
are shown in lanes 1 through 6, respectively. Fragments were analyzed
by electrophoresis on a 1% agarose gel in the presence of ethidium
bromide. Lanes M = marker DNA fragments with sizes as indicated.
|
|
Synthesis of viral RNAs and proteins.
The recovered viruses
were next examined for their levels of gene expression. Synthesis of
viral RNAs and proteins by the variant viruses was examined by
metabolic incorporation of [3H]uridine or
[35S]methionine into infected cells, and analysis of
the radiolabeled products by gel electrophoresis. The same
species of viral RNAs were made in cells infected with the
wild-type virus and with each of the variants: the 11.16-kb
genomic RNA and mRNAs representing the L, G, N, P, and M genes
(Fig. 3a). The latter two mRNAs are similar in size and comigrated during electrophoresis (44). No novel or aberrant RNA species were found in cells infected with the
variant viruses, showing that the virus preparations were free of DI
particles (Fig. 3a). Moreover, the similarities among the RNA patterns
reinforced the idea that the behavior of the viral polymerase during
transcription across the intergenic junctions was determined
exclusively by local sequence elements at these positions, with no
detectable long-range influences (4, 5, 38). In accordance
with the RNA patterns, the viral proteins made by the variant viruses
also resembled qualitatively those made during wild-type infection
(Fig. 3b).

View larger version (35K):
[in this window]
[in a new window]
|
FIG. 3.
(a) Viral RNAs synthesized in BHK-21 cells that were
infected with the wild-type and variant viruses. Viral RNAs were
labeled with [3H]uridine as described in Materials and
Methods, resolved by electrophoresis on an agarose-urea gel, and
detected by fluorography. The infecting viruses are shown above the
lanes, and the viral RNAs are identified on the left. (b) Viral
proteins synthesized in BHK-21 cells that were infected with the
wild-type and variant viruses. Viral proteins were labeled with
[35S]methionine as described in Materials and Methods,
resolved by electrophoresis on an SDS-polyacrylamide gel, and detected
by autoradiography. The infecting viruses are shown above the lanes,
and the viral proteins are identified on the left. Uninf, uninfected
cells.
|
|
Although the RNA and protein profiles of cells infected with the
wild-type and variant viruses were qualitatively similar,
measurement
of the relative levels of the different RNAs and proteins
showed that
the variant viruses expressed their genes in molar
ratios that differed
from both the wild type and one another (Fig.
4). Normalizing the expression of each
protein to that of the
promoter-proximal N gene for each variant virus
showed that the
relative expression level of a gene depended primarily
on its
location in the genome and thus on its distance from the
promoter,
just as predicted by the model of progressive transcriptional
attenuation. This is clearly exemplified by comparison of the
molar
ratios of proteins expressed by the wild-type (PMG) with
variant GMP in
which the order of the three internal genes is
reversed (Fig.
4). A
similar quantitative analysis of the mRNA
profiles was complicated by
the lack of resolution of the M and
P mRNAs (Fig.
3a), but measurement
of the L, G, and N mRNA levels
reinforced the conclusion that the
proximity of a gene to the
3' end of the viral genome was the major
determinant of its level
of transcription. For example, the differences
in the relative
abundance of G mRNA reflected the position of the G
gene (Fig.
3a). The RNA profiles also showed that the level of RNA
replication,
as measured by the abundance of the 11.1-kb genomic and
antigenomic
RNAs, differed substantially among the variants (Fig.
3a).

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 4.
Molar ratios of viral proteins synthesized in BHK-21
cells that were infected with the wild-type and variant viruses.
Proteins were labeled as described in Materials and Methods, resolved
on SDS-polyacrylamide gels as shown in Fig. 3b, and quantitated by
phosphorimaging. Molar ratios were calculated after normalizing for the
methionine contents of the individual proteins: N-14, P-5, M-11, G-10,
and L-60 (35).
|
|
Replication of viruses with rearranged genomes.
The variant
viruses were compared for their ability to replicate under the
conditions of plaque formation and single-cycle growth. Although some
of the viruses such as MGP and MPG were indistinguishable from the N1
wild-type virus (PMG) in these assays, others such as GMP, GPM, and PGM
formed significantly smaller plaques than the wild type on monolayers
of BSC-1 cells (Table 1). Moreover, GMP plaques ceased to grow after
24 h when those of the wild-type virus and the other variants were
still increasing in size (Table 1). The
impaired replication of GMP, GPM, and PGM was also demonstrated during
single-cycle growth on BSC-1 cells (Fig.
5). At 17 h postinfection, the
incremental yields of the variants averaged over three independent
growths and expressed as percentages of the wild-type were as follows:
for MGP, 107%; for MPG, 51%; for GMP, 23%; for PGM, 21%; and for
GPM, 1.6% (Table 2).

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 5.
Single-step growth curves of wild-type VSV and the
rearranged variants in BSC-1 cells. Viral titers were measured in
duplicate at each time point during three independent single-step
growth experiments at 37°C, and the results were averaged.
|
|
Virulence in mice.
Intracerebral or intranasal inoculation of
wild-type VSV into mice causes fatal encephalitis. Since 1938, when
Sabin and Olitsky first described the neuropathology and comparative
susceptibility of mice to VSV encephalitis as a function of age and
route of inoculation (36), young mice have served as a
convenient and sensitive small animal model for comparing the lethality
of VSV and its mutants (42, 49). We therefore examined the
pathogenesis of the variant viruses in mice.
Intranasal inoculation of wild-type VSV into 3- to 4-week-old mice
causes encephalitis, paralysis, and death after 7 to 11
days
(
42), with the LD
50 dose being about 10 PFU. We
compared
the virulence of the variant viruses by inoculating groups of
mice by this route with serial 10-fold dilutions ranging from
0.1 to
1,000 PFU per dose and observing them twice daily. Viral
gene orders
were verified on viruses recovered shortly after death
from the brains
of inoculated mice by using the methodology shown
in Fig.
2. In each
case, the gene order of the recovered virus
corresponded to that of the
inoculum (data not
shown).
The LD
50 doses for the variant viruses were similar to that
of the wild type, with viruses GPM, GMP, and MGP requiring slightly
higher (1.5- to 2-fold) doses (Table
2). These experiments were
repeated three times, and the results of a representative experiment
(Fig.
6) show the time of appearance of
illness and death at a
dose of 100 PFU per mouse. The
wild-type-infected animals first
appeared sick at 6 days
postinoculation, rapidly became paralyzed,
and died within 2 weeks.
Recombinants GMP and MGP elicited reproducibly
faster pathogenesis,
with symptoms developing 24 to 36 h earlier
than in
wild-type-infected animals, whereas the onset of death
from infection
with MPG and GPM occurred 24 to 36 h later (Fig.
6). In general,
the paralysis that is typical of infection with
wild-type VSV was less
apparent with the variant viruses, but
there was no evidence of
persistent nervous system disease such
as that produced by some M
protein mutants (
17).

View larger version (35K):
[in this window]
[in a new window]
|
FIG. 6.
Pathogenesis of wild-type (wt) and variant viruses
following intranasal inoculation into mice. The time course of
morbidity (gray bars) and mortality (black bars) in animals that
received intranasal inoculation of 100 PFU of each of the variant
viruses is shown. No further changes occurred after the time periods
shown.
|
|
Virulence in mice could not be predicted from the cell culture
phenotypes of the variant viruses (Table
2). Of the three
recombinants
whose replication in cell culture was most compromised
(GMP, PGM, and
GPM), one (GPM) required twofold more virus for
an LD
50
than the wild type and showed slightly delayed killing
in mice, whereas
GMP induced faster onset of symptoms and death,
and PGM was
indistinguishable from wild type. This lack of correlation
between the
behavior of viruses in cell culture and their properties
in animals is
a familiar observation among different animal viruses
but is
interesting in this context, in which the only differences
between the
viruses were the relative levels of wild-type proteins
they
expressed.
 |
DISCUSSION |
The results presented above show that the three central genes in
the VSV genome can be rearranged into all six possible orders (one of which is the wild-type order) without eliminating
infectivity. This work extends our earlier recovery of viable variants
in which the VSV N protein gene was moved from its promoter-proximal
position to become the second, third, or fourth gene in the genome
(45), and together with the recovery of infectious viruses
with the gene orders GNPML and GPMNL (data not shown), it brings to 10 the total number of viable gene order variants of VSV constructed to date.
Evidently, the VSV genome can accommodate a significant degree of
reorganization. Our results show that several different gene orders are
compatible with virus replication, despite the fact that the
natural gene order is strongly conserved among the Mononegavirales (32). Comparisons across the
entire order of viruses suggest that little, if any, homologous
recombination has occurred during their evolution from a presumed
common ancestor, and all experimental attempts to detect homologous
recombination have failed (30). Although the total number of
viral genes differs among the Mononegavirales, there is
little evidence that the conserved intergenic junction sequences have
served as recombination sites to mediate gene rearrangement (30,
32). Our results indicate that this is not because rearrangement
is necessarily lethal or even detrimental to the virus, because MGP and
MPG replicated as well as the wild-type virus. Instead, it seems more
likely that conservation results from the ancestral gene order being immobilized by the lack of a mechanism for homologous recombination.
A consequence of this is that natural processes should not be able to
reverse experimental gene rearrangements such as those described above.
Given the intrinsically high error rates of the viral RNA
polymerases, their lack of proofreading mechanisms and the
resulting genetic instability of these viruses (11),
changing the gene order may be a unique way to create stable variants
with desirable phenotypes. Indeed, we have shown that moving the VSV N
gene from its promoter-proximal position progressively further down the
viral genome systematically attenuates the virus without compromising
its immunogenicity, thus creating a promising prototype for a
novel live attenuated vaccine (45). The ability of the VSV genome to accommodate significant reorganization enhances the
prospects of the use of the virus as a vector.
Since the variants described here were constructed by rearranging the
viral genes without introducing other mutations, the phenotypic
consequences could be unambiguously attributed to translocation of the
genes and the resulting effects on their expression. The levels of
viral protein synthesis accurately reflected the positions of the genes
with respect to the 3' end of the genome (Fig. 4), directly
demonstrating that gene expression was regulated primarily by
transcriptional attenuation. Moreover, the results confirmed that the
level of attenuation at the first three intergenic junctions was
determined principally by the conserved sequence elements in their
immediate vicinity, with no detectable long-range influences (5,
38, 40). However, in the wild-type virus, transcriptional attenuation is greater at the G-L boundary than at the preceding junctions, and the same was true at the P-L and M-L junctions in the
pertinent variants (Fig. 3a and 4). Since the same effect was seen at
an N-L junction (45), these results suggest that the
unusually high transcriptional attenuation at this position may be due
to cis-acting signals in the L gene itself.
Our previous experience of the sensitivity of VSV RNA replication to
the N:P:L protein ratios led us to anticipate that some of the gene
rearrangements would be lethal (28). In particular, we
expected severe phenotypic consequences to result from both the
underexpression of P protein, which acts as a chaperone to incorporate
N into assembling nucleocapsids (10, 16, 19), and the
overexpression of M protein, which inhibits viral transcription (8, 9, 21) and condenses the viral nucleocapsids in
preparation for particle formation (22, 24). Although more
severe perturbations of the levels of viral proteins would doubtless
have more profound effects on the viral phenotype, variant MGP, which
combined these features, replicated in cell culture about as well as
the wild-type virus and had a similar LD50 in mice (Fig. 5
and Table 2). Variant MPG also resembled the wild-type virus both in
cell culture and in mice. In contrast, the two variants that
underexpressed M protein (PGM and GPM) replicated the least well in
cell culture (Fig. 5), although they were not correspondingly
attenuated in mice (Fig. 6 and Table 2). Contrary to expectations,
therefore, the level of M protein expression correlated most closely
with the level of replication in cell culture. The lack of a
straightforward concordance between the replication of the variants in
cell culture and their virulence in mice illustrates the well-known
limitations of cell culture methods for studying the biological
properties of animal viruses.
One key to understanding these disparate phenotypes may be provided by
the properties of variant GMP, which underexpressed P protein compared
with the wild-type virus (Fig. 4), and whose plaques ceased to grow
before those of the other viruses (Table 1). Similar plaquing
behavior was seen with some conventional mutants of VSV that were
defective in shutting off host protein synthesis (14, 39,
46, 49). Unlike the wild-type virus, these mutants induced high
levels of interferon, which prematurely arrested plaque development,
and it is possible that variant GMP also interacted anomalously with
the interferon system, either by inducing unusually high levels of
interferon or by being particularly sensitive to its action.
Alternatively, variations in the rate of DI particle generation could
have contributed to the differences in plaquing behavior, although the
input virus stocks were free of DI particles as shown by their
intracellular RNA profiles (Fig. 3a). Experiments are in progress to
examine these possibilities.
Plaques of variant MGP, unlike those of GMP, did not stop growing
prematurely (Table 1). This may be attributable to the overexpression
of M protein by the former variant and the documented ability of M to
repress the transcription of cellular genes (2, 6, 25),
including that for interferon
(13). Similarly, differences in the shut-off of host cell transcription and translation and the consequent effects on interferon induction and action could
also explain why variants PGM and GPM replicated so poorly in cell
culture. However, direct measurement of the kinetics of host cell
shut-off and interferon induction and action will be necessary to
substantiate these ideas, and further studies will be required to fully
explain the altered phenotypes of the variant viruses in molecular terms.
Although the gene orders of viruses recovered from the brains of dead
mice were found invariably to correspond to those of the inoculated
viruses, serial passage of the variants either in cell culture or in
animals may select for mutations that compensate for the unbalanced
patterns of gene expression. Recent work has shown that mutating the
conserved nucleotides at the intergenic junction of a model bicistronic
VSV replicon can profoundly affect the degree of both transcriptional
attenuation (4, 40) and termination (4, 5, 40).
In the genome of a variant virus, however, such mutations would confer
only a limited benefit, because they would necessarily have pleiotropic
effects on the expression of all downstream genes. Nevertheless, if
compensating mutations arise during serial passage of the variants
either in cell culture or in animals, they should provide valuable
insights into the mechanism of VSV gene regulation and the nature of
the selective pressures encountered by viruses in these distinct environments.
In summary, these results show that despite the strong conservation of
gene order among the Mononegavirales, several variants of VSV with different gene orders are viable, and some of them show altered phenotypes both in cell culture and in mice. This ability
to accommodate major genetic changes more readily than might have been
expected from phylogenetic data augments VSV's potential for
development as an expression vector and recombinant vaccine. The
same method of gene rearrangement could be applied to any of the
Mononegavirales for which an infectious cDNA clone is
available, and many aspects of virus biology, including replication, pathogenesis, and evolution, should be illuminated by detailed studies
of these and similar viruses. In general, the approach of rearranging
viral genes to effect changes in gene expression provides an
opportunity for the generation of viral phenotypes that may prove
valuable for the analysis of virus-host interactions and for optimizing
the potential of these viruses as vectors in many different contexts.
 |
ACKNOWLEDGMENTS |
We thank Seán Whelan for suggesting the cloning strategy
that was used to rearrange the genes and Fenglan Li for excellent technical help.
This work was supported by Public Health Service grants R37 AI 12464 to
G.W.W. and R37 AI 18270 to L.A.B.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Microbiology
Department, UAB, BBRB 373/17, 845 19th St. South, Birmingham, AL 35294. Phone: (205) 934-0864. Fax: (205) 934-1636. E-mail:
Andyb{at}uab.edu.
 |
REFERENCES |
| 1.
|
Abraham, G., and A. K. Banerjee.
1976.
Sequential transcription of the genes of vesicular stomatitis virus.
Proc. Natl. Acad. Sci. USA
73:1504-1508[Abstract/Free Full Text].
|
| 2.
|
Ahmed, M., and D. S. Lyles.
1998.
Effect of vesicular stomatitis virus matrix protein on transcription directed by host polymerases I, II, and III.
J. Virol.
72:8413-8419[Abstract/Free Full Text].
|
| 3.
|
Ball, L. A., and C. N. White.
1976.
Order of transcription of genes of vesicular stomatitis virus.
Proc. Natl. Acad. Sci. USA
73:442-446[Abstract/Free Full Text].
|
| 4.
|
Barr, J. N.,
S. P. Whelan, and G. W. Wertz.
1997.
Role of the intergenic dinucleotide in vesicular stomatitis virus RNA transcription.
J. Virol.
71:1794-1801[Abstract].
|
| 5.
|
Barr, J. N.,
S. P. J. Whelan, and G. W. Wertz.
1997.
The cis-acting signals involved in termination of VSV mRNA synthesis include the conserved AUAC and the U7 signal for polyadenylation.
J. Virol.
71:8718-8725[Abstract].
|
| 6.
|
Black, B. L., and D. S. Lyles.
1992.
Vesicular stomatitis virus matrix protein inhibits host cell-directed transcription of target genes in vivo.
J. Virol.
66:4058-4064[Abstract/Free Full Text].
|
| 7.
|
Blondel, D.,
G. G. Harmison, and M. Schubert.
1990.
Role of matrix protein in cytopathogenesis of vesicular stomatitis virus.
J. Virol.
64:1716-1725[Abstract/Free Full Text].
|
| 8.
|
Carroll, A. R., and R. R. Wagner.
1979.
Role of the membrane (M) protein in endogenous inhibition of in vitro transcription of vesicular stomatitis virus.
J. Virol.
29:134-142[Abstract/Free Full Text].
|
| 9.
|
Clinton, G. M.,
S. P. Little,
F. S. Hagen, and A. S. Huang.
1978.
The matrix (M) protein of vesicular stomatitis virus regulates transcription.
Cell
15:1455-1462[Medline].
|
| 10.
|
Davis, N. L.,
H. Arnheiter, and G. W. Wertz.
1986.
Vesicular stomatitis virus N and NS proteins from multiple complexes.
J. Virol.
59:751-754[Abstract/Free Full Text].
|
| 11.
|
Domingo, E.,
C. Escarmis,
N. Sevilla,
A. Moya,
S. F. Elena,
J. Quer,
I. S. Novella, and J. J. Holland.
1996.
Basic concepts in RNA virus evolution.
FASEB J.
10:859-864[Abstract].
|
| 12.
|
Emerson, S. U., and Y.-H. Yu.
1975.
Both NS and L proteins are required for in vitro RNA synthesis by vesicular stomatitis virus.
J. Virol.
15:1348-1356[Abstract/Free Full Text].
|
| 13.
|
Ferran, M., and J. M. Lucas-Lenard.
1997.
The vesicular stomatitis virus matrix protein inhibits transcription from the human beta interferon promoter.
J. Virol.
71:371-377[Abstract].
|
| 14.
|
Francoeur, A. M.,
L. Poliquin, and C. P. Stanners.
1987.
The isolation of interferon-inducing mutants of vesicular stomatitis virus with altered viral P function for the inhibition of total protein synthesis.
Virology
160:236-245[Medline].
|
| 15.
|
Fuerst, T. R.,
E. G. Niles,
F. W. Studier, and B. Moss.
1986.
Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.
Proc. Natl. Acad. Sci. USA
83:8122-8126[Abstract/Free Full Text].
|
| 16.
|
Howard, M., and G. Wertz.
1989.
Vesicular stomatitis virus RNA replication: a role for the NS protein.
J. Gen. Virol.
70:2683-2694[Abstract/Free Full Text].
|
| 17.
|
Hughes, J. V.,
T. C. Johnson,
S. G. Rabinowitz, and M. C. Dal Canto.
1979.
Growth and maturation of a vesicular stomatitis virus temperature-sensitive mutant and its central nervous system isolate.
J. Virol.
29:312-321[Abstract/Free Full Text].
|
| 18.
|
Iverson, L. E., and J. K. Rose.
1981.
Localized attenuation and discontinuous synthesis during vesicular stomatitis virus transcription.
Cell
23:477-484[Medline].
|
| 19.
|
La Ferla, F. M., and R. W. Peluso.
1989.
The 1:1 N-NS protein complex of vesicular stomatitis virus is essential for efficient genome replication.
J. Virol.
63:3852-3857[Abstract/Free Full Text].
|
| 20.
|
Lefkowitz, E. J.,
A. K. Pattnaik, and L. A. Ball.
1990.
Complementation of a vesicular stomatitis virus glycoprotein G mutant with wild-type protein expressed from either a bovine papilloma virus or a vaccinia virus vector system.
Virology
178:373-383[Medline].
|
| 21.
|
Li, Y.,
L. Luo, and R. R. Wagner.
1989.
Transcription inhibition site on the M protein of vesicular stomatitis virus located by marker rescue of mutant tsO23(III) with M-gene expression vectors.
J. Virol.
63:2841-2843[Abstract/Free Full Text].
|
| 22.
|
Lyles, D. S.,
M. O. McKenzie,
P. E. Kaptur,
K. W. Grant, and W. G. Jerome.
1996.
Complementation of M gene mutants of vesicular stomatitis virus by plasmid-derived M protein converts spherical extracellular particles into native bullet shapes.
Virology
217:76-87[Medline].
|
| 23.
|
Meier, E.,
G. G. Harmison, and M. Schubert.
1987.
Homotypic and heterotypic exclusion of vesicular stomatitis virus replication by high levels of recombinant polymerase protein L.
J. Virol.
61:3133-3142[Abstract/Free Full Text].
|
| 24.
|
Odenwald, W. F.,
H. Arnheiter,
M. Dubois-Dalcq, and R. A. Lazzarini.
1986.
Stereo images of vesicular stomatitis virus assembly.
J. Virol.
57:922-932[Abstract/Free Full Text].
|
| 25.
|
Paik, S.-Y.,
A. C. Banerjea,
G. G. Harmison,
C.-J. Chen, and M. Schubert.
1995.
Inducible and conditional inhibition of human immunodeficiency virus proviral expression by vesicular stomatitis virus matrix protein.
J. Virol.
69:3529-3537[Abstract].
|
| 26.
|
Pal, R.,
R. W. Grinnell,
R. M. Snyder, and R. R. Wagner.
1985.
Regulation of viral transcription by the matrix protein of vesicular stomatitis virus probed by monoclonal antibodies and temperature-sensitive mutants.
J. Virol.
56:386-394[Abstract/Free Full Text].
|
| 27.
|
Pattnaik, A. K.,
L. A. Ball,
A. W. LeGrone, and G. W. Wertz.
1992.
Infectious defective interfering particles of VSV from transcripts of a cDNA clone.
Cell
69:1011-1020[Medline].
|
| 28.
|
Pattnaik, A. K., and G. W. Wertz.
1991.
Cells that express all five proteins of vesicular stomatitis virus from cloned cDNAs support replication, assembly, and budding of defective interfering particles.
Proc. Natl. Acad. Sci. USA
88:1379-1383[Abstract/Free Full Text].
|
| 29.
|
Pattnaik, A. K., and G. W. Wertz.
1990.
Replication and amplification of defective interfering particle RNAs of vesicular stomatitis virus in cells expressing viral proteins from vectors containing cloned cDNAs.
J. Virol.
64:2948-2957[Abstract/Free Full Text].
|
| 30.
|
Pringle, C. R.
1991.
The genetics of paramyxoviruses, p. 1-39.
In
D. Kingsbury (ed.), The paramyxoviruses. Plenum Press, New York, N.Y.
|
| 31.
|
Pringle, C. R.
1982.
The genetics of vesiculoviruses.
Arch. Virol.
72:1-34[Medline].
|
| 32.
|
Pringle, C. R., and A. J. Easton.
1997.
Monopartite negative strand RNA genomes.
Semin. Virol.
8:49-57.
|
| 33.
|
Reed, E. J., and H. Muench.
1938.
A simple method of estimating fifty percent endpoints.
Am. J. Hyg.
27:493-497.
|
| 34.
|
Richardson, J. H., and W. E. Barkley (ed.).
1988.
Biosafety in microbiological and biomedical laboratories, 2nd ed.
USDHHS: Centers for Disease Control and Prevention, and National Institutes of Health, Atlanta, Ga. and Bethesda, Md..
|
| 35.
|
Rose, J., and M. Schubert.
1987.
Rhabdovirus genomes and their products, p. 127-166.
In
R. R. Wagner (ed.), The rhabdoviruses. Plenum Press, New York, N.Y.
|
| 36.
|
Sabin, A., and P. Olitsky.
1938.
Influence of host factors on neuroinvasiveness of vesicular stomatitis virus.
J. Exp. Med.
67:201-227[Abstract].
|
| 37.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 38.
|
Schnell, M. J.,
L. Buonocore,
M. A. Whitt, and J. K. Rose.
1996.
The minimal conserved transcription stop-start signal promotes stable expression of a foreign gene in vesicular stomatitis virus.
J. Virol.
70:2318-2323[Abstract].
|
| 39.
|
Stanners, C. P.,
A. M. Francoeur, and T. Lam.
1977.
Analysis of VSV mutant with attenuated cytopathogenicity: mutation in viral function, P, for inhibition of protein synthesis.
Cell
11:273-281[Medline].
|
| 40.
|
Stillman, E. A., and M. A. Whitt.
1997.
Mutational analysis of the intergenic dinucleotide and the transcriptional start sequence of vesicular stomatitis virus (VSV) define sequences required for efficient termination and initiation of VSV transcripts.
J. Virol.
71:2127-2137[Abstract].
|
| 41.
|
Villarreal, L. P.,
M. Breindl, and J. J. Holland.
1976.
Determination of molar ratios of vesicular stomatitis virus induced RNA species in BHK21 cells.
Biochemistry
15:1663-1667[Medline].
|
| 42.
|
Wagner, R. R.
1974.
Pathogenicity and immunogenicity for mice of temperature-sensitive mutants of vesicular stomatitis virus.
Infect. Immun.
10:309-315[Abstract/Free Full Text].
|
| 43.
|
Wertz, G. W., and N. Davis.
1981.
Characterization of mapping of RNase III cleavage sites in VSV genome RNA.
Nucleic Acids Res.
9:6487-6503[Abstract/Free Full Text].
|
| 44.
|
Wertz, G. W., and N. L. Davis.
1979.
RNase III cleaves vesicular stomatitis virus genome-length RNAs but fails to cleave viral mRNA's.
J. Virol.
30:108-115[Abstract/Free Full Text].
|
| 45.
|
Wertz, G. W.,
V. P. Perepelitsa, and L. A. Ball.
1998.
Gene rearrangement attenuates expression and lethality of a non-segmented negative strand RNA virus.
Proc. Natl. Acad. Sci. USA
95:3501-3506[Abstract/Free Full Text].
|
| 46.
|
Wertz, G. W., and J. S. Youngner.
1970.
Interferon production and inhibition of host synthesis in cells infected with vesicular stomatitis virus.
J. Virol.
6:476-484[Abstract/Free Full Text].
|
| 47.
|
Whelan, S. P. J.,
L. A. Ball,
J. N. Barr, and G. T. W. Wertz.
1995.
Recovery of infectious vesicular stomatitis virus entirely from cDNA clones.
Proc. Natl. Acad. Sci. USA
92:8388-8392[Abstract/Free Full Text].
|
| 48.
|
Whitt, M. A.,
L. Chong, and J. K. Rose.
1989.
Glycoprotein cytoplasmic domain sequences required for rescue of a vesicular stomatitis virus glycoprotein mutant.
J. Virol.
63:3569-3578[Abstract/Free Full Text].
|
| 49.
|
Youngner, J. S., and G. Wertz.
1968.
Interferon production in mice by vesicular stomatitis virus.
J. Virol.
2:1360-1361[Free Full Text].
|
Journal of Virology, June 1999, p. 4705-4712, Vol. 73, No. 6
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Clarke, D. K., Nasar, F., Lee, M., Johnson, J. E., Wright, K., Calderon, P., Guo, M., Natuk, R., Cooper, D., Hendry, R. M., Udem, S. A.
(2007). Synergistic Attenuation of Vesicular Stomatitis Virus by Combination of Specific G Gene Truncations and N Gene Translocations. J. Virol.
81: 2056-2064
[Abstract]
[Full Text]
-
Majid, A. M., Ezelle, H., Shah, S., Barber, G. N.
(2006). Evaluating Replication-Defective Vesicular Stomatitis Virus as a Vaccine Vehicle. J. Virol.
80: 6993-7008
[Abstract]
[Full Text]
-
Martinez, I., Wertz, G. W.
(2005). Biological Differences between Vesicular Stomatitis Virus Indiana and New Jersey Serotype Glycoproteins: Identification of Amino Acid Residues Modulating pH-Dependent Infectivity. J. Virol.
79: 3578-3585
[Abstract]
[Full Text]
-
Faber, M., Pulmanausahakul, R., Nagao, K., Prosniak, M., Rice, A. B., Koprowski, H., Schnell, M. J., Dietzschold, B.
(2004). Identification of viral genomic elements responsible for rabies virus neuroinvasiveness. Proc. Natl. Acad. Sci. USA
101: 16328-16332
[Abstract]
[Full Text]
-
Novella, I. S., Ball, L. A., Wertz, G. W.
(2004). Fitness Analyses of Vesicular Stomatitis Strains with Rearranged Genomes Reveal Replicative Disadvantages. J. Virol.
78: 9837-9841
[Abstract]
[Full Text]
-
Martinez, I., Rodriguez, L. L., Jimenez, C., Pauszek, S. J., Wertz, G. W.
(2003). Vesicular Stomatitis Virus Glycoprotein Is a Determinant of Pathogenesis in Swine, a Natural Host. J. Virol.
77: 8039-8047
[Abstract]
[Full Text]
-
Flanagan, E. B., Schoeb, T. R., Wertz, G. W.
(2003). Vesicular Stomatitis Viruses with Rearranged Genomes Have Altered Invasiveness and Neuropathogenesis in Mice. J. Virol.
77: 5740-5748
[Abstract]
[Full Text]
-
McGettigan, J. P., Pomerantz, R. J., Siler, C. A., McKenna, P. M., Foley, H. D., Dietzschold, B., Schnell, M. J.
(2002). Second-Generation Rabies Virus-Based Vaccine Vectors Expressing Human Immunodeficiency Virus Type 1 Gag Have Greatly Reduced Pathogenicity but Are Highly Immunogenic. J. Virol.
77: 237-244
[Abstract]
[Full Text]
-
de Haan, C. A. M., Volders, H., Koetzner, C. A., Masters, P. S., Rottier, P. J. M.
(2002). Coronaviruses Maintain Viability despite Dramatic Rearrangements of the Strictly Conserved Genome Organization. J. Virol.
76: 12491-12502
[Abstract]
[Full Text]
-
Neumann, G., Whitt, M. A., Kawaoka, Y.
(2002). A decade after the generation of a negative-sense RNA virus from cloned cDNA - what have we learned?. J. Gen. Virol.
83: 2635-2662
[Abstract]
[Full Text]
-
Krempl, C., Murphy, B. R., Collins, P. L.
(2002). Recombinant Respiratory Syncytial Virus with the G and F Genes Shifted to the Promoter-Proximal Positions. J. Virol.
76: 11931-11942
[Abstract]
[Full Text]
-
Hinzman, E. E., Barr, J. N., Wertz, G. W.
(2002). Identification of an Upstream Sequence Element Required for Vesicular Stomatitis Virus mRNA Transcription. J. Virol.
76: 7632-7641
[Abstract]
[Full Text]
-
Wertz, G. W., Moudy, R., Ball, L. A.
(2002). Adding Genes to the RNA Genome of Vesicular Stomatitis Virus: Positional Effects on Stability of Expression. J. Virol.
76: 7642-7650
[Abstract]
[Full Text]
-
Faber, M., Pulmanausahakul, R., Hodawadekar, S. S., Spitsin, S., McGettigan, J. P., Schnell, M. J., Dietzschold, B.
(2002). Overexpression of the Rabies Virus Glycoprotein Results in Enhancement of Apoptosis and Antiviral Immune Response. J. Virol.
76: 3374-3381
[Abstract]
[Full Text]
-
Rokyta, D., Badgett, M. R., Molineux, I. J., Bull, J. J.
(2002). Experimental Genomic Evolution: Extensive Compensation for Loss of DNA Ligase Activity in a Virus. Mol Biol Evol
19: 230-238
[Abstract]
[Full Text]
-
Fernandez, M., Porosnicu, M., Markovic, D., Barber, G. N.
(2002). Genetically Engineered Vesicular Stomatitis Virus in Gene Therapy: Application for Treatment of Malignant Disease. J. Virol.
76: 895-904
[Abstract]
[Full Text]
-
Badrane, H., Tordo, N.
(2001). Host Switching in Lyssavirus History from the Chiroptera to the Carnivora Orders. J. Virol.
75: 8096-8104
[Abstract]
[Full Text]
-
Dirks, C., Miller, A. D.
(2001). Many Nonmammalian Cells Exhibit Postentry Blocks to Transduction by Gammaretroviruses Pseudotyped with Various Viral Envelopes, Including Vesicular Stomatitis Virus G Glycoprotein. J. Virol.
75: 6375-6383
[Abstract]
[Full Text]
-
Flanagan, E. B., Zamparo, J. M., Ball, L. A., Rodriguez, L. L., Wertz, G. W.
(2001). Rearrangement of the Genes of Vesicular Stomatitis Virus Eliminates Clinical Disease in the Natural Host: New Strategy for Vaccine Development. J. Virol.
75: 6107-6114
[Abstract]
[Full Text]
-
Walsh, E. P., Baron, M. D., Rennie, L. F., Monaghan, P., Anderson, J., Barrett, T.
(2000). Recombinant Rinderpest Vaccines Expressing Membrane-Anchored Proteins as Genetic Markers: Evidence of Exclusion of Marker Protein from the Virus Envelope. J. Virol.
74: 10165-10175
[Abstract]
[Full Text]
-
Flanagan, E. B., Ball, L. A., Wertz, G. W.
(2000). Moving the Glycoprotein Gene of Vesicular Stomatitis Virus to Promoter-Proximal Positions Accelerates and Enhances the Protective Immune Response. J. Virol.
74: 7895-7902
[Abstract]
[Full Text]
-
Endy, D., You, L., Yin, J., Molineux, I. J.
(2000). Computation, prediction, and experimental tests of fitness for bacteriophage T7 mutants with permuted genomes. Proc. Natl. Acad. Sci. USA
97: 5375-5380
[Abstract]
[Full Text]